在莫加莫珠单抗诱导的史蒂文斯-约翰逊综合征发病机制中调节性FoxP3 T细胞的耗竭 - Suppr | 超能文献

Depletion of regulatory FoxP3 T cells in the pathogenesis of Stevens-Johnson syndrome induced by mogamulizumab.

作者信息

Amakata Masato, Teraki Yuichi

机构信息

Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.

出版信息

Int J Dermatol. 2019 Dec;58(12):e247-e249. doi: 10.1111/ijd.14592. Epub 2019 Jul 23.

DOI:10.1111/ijd.14592

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Depletion of regulatory FoxP3 T cells in the pathogenesis of Stevens-Johnson syndrome induced by mogamulizumab.在莫加莫珠单抗诱导的史蒂文斯-约翰逊综合征发病机制中调节性FoxP3 T细胞的耗竭

Int J Dermatol. 2019 Dec;58(12):e247-e249. doi: 10.1111/ijd.14592. Epub 2019 Jul 23.

2

Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma.Stevens-Johnson 综合征与莫格利珠单抗治疗成人 T 细胞白血病/淋巴瘤相关。

Cancer Sci. 2013 May;104(5):647-50. doi: 10.1111/cas.12116. Epub 2013 Mar 10.

3

Stevens-Johnson Syndrome Associated with Mogamulizumab-induced Deficiency of Regulatory T cells in an Adult T-cell Leukaemia Patient.莫加莫珠单抗诱导调节性T细胞缺乏与成人T细胞白血病患者的史蒂文斯-约翰逊综合征

Acta Derm Venereol. 2015 May;95(5):606-7. doi: 10.2340/00015555-2027.

4

Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia/lymphoma.莫加莫拉单抗诱发的迟发性中毒性表皮坏死松解症，莫加莫拉单抗是一种用于治疗成人T细胞白血病/淋巴瘤的抗CC趋化因子受体4抗体。

Hematol Oncol. 2017 Mar;35(1):138-140. doi: 10.1002/hon.2242. Epub 2015 Jul 14.

5

CD8+ T-cell-mediated Interface Dermatitis after CCR4+ T-cell Depletion by Mogamulizumab Treatment of Adult T-cell Leukaemia/lymphoma.莫加莫珠单抗治疗成人T细胞白血病/淋巴瘤导致CCR4 + T细胞耗竭后CD8 + T细胞介导的界面性皮炎

Acta Derm Venereol. 2017 Mar 10;97(3):377-378. doi: 10.2340/00015555-2555.

6

Toxic epidermal necrolysis in adult T cell leukemia/lymphoma treated with mogamulizumab.用莫加莫拉单抗治疗的成人T细胞白血病/淋巴瘤中的中毒性表皮坏死松解症。

Ann Hematol. 2016 Mar;95(4):661-2. doi: 10.1007/s00277-016-2594-1. Epub 2016 Jan 11.

7

Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma.莫格利珠单抗治疗引发成人 T 细胞白血病/淋巴瘤患者的皮肤自身抗体攻击。

Clin Cancer Res. 2019 Jul 15;25(14):4388-4399. doi: 10.1158/1078-0432.CCR-18-2575. Epub 2019 Apr 24.

8

Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.抗CCR4单克隆抗体（莫加莫拉单抗）对成人T细胞白血病-淋巴瘤的影响：皮肤不良反应可能预测预后。

J Dermatol. 2014 Mar;41(3):239-44. doi: 10.1111/1346-8138.12419.

9

Cutaneous adverse reaction of mogamulizumab, an anti-CC chemokine receptor 4 monoclonal antibody: Shared histopathological features with thymoma-associated multi-organ autoimmunity.抗CC趋化因子受体4单克隆抗体莫加莫拉izumab的皮肤不良反应：与胸腺瘤相关的多器官自身免疫的共同组织病理学特征

J Dermatol. 2017 Jun;44(6):e117-e118. doi: 10.1111/1346-8138.13738. Epub 2016 Dec 27.

10

Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.同种异体造血干细胞移植后复发的成人 T 细胞白血病/淋巴瘤发生中毒性表皮坏死松解症后的完全缓解。

Int J Hematol. 2019 Oct;110(4):506-511. doi: 10.1007/s12185-019-02675-1. Epub 2019 May 31.

引用本文的文献

1

Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的当前药物遗传学观点

Front Pharmacol. 2021 Apr 26;12:588063. doi: 10.3389/fphar.2021.588063. eCollection 2021.